Similarly, in transwell assays, Notch3-mediated inhibition of cell migration and invasion of breast cancer cells was partially reversed by suppressing the Notch3 downstream target STAT5A (Fig. 5b). This evidence concerns the gene NOTCH3 and breast carcinoma.